US Stock Market Closed

Dashboard

Molecular Templates, Inc. (MTEM)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

S

Analyst Opinion

B

Leverage & Liquidity

B

Fundamental Variables

H

Rating Performance

FV Performance

*There is a current rating on the stock that is included in these numbers based on its performance so far

About

Molecular Templates, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. The company utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. Molecular Templates was founded by Eric E. Poma, Jean Gariépy and Leigh Revers on October 17, 2001 and is headquartered in Austin, TX.

CEO

Eric E. Poma

Employees

168

Industry

Oncology Biopharmaceuticals

Sector

Healthcare

Headquarters

Austin

Exchange

NASDAQ

Summary Stats

Market Cap

55.6M

Revenue

44M

Net Income

-77.8M

EPS

-$1.38

Price-to-Earnings

-0.72

Price-to-Book

1.17

Debt-to-Equity

2.44

News

Analyst Ratings

Price targets projected by 6 analysts

High

$22.00

Average

$17.83

Low

$13.00

Ratings calculated by 8 analysts

Buy

8

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q1 2022

Last Earnings

Not Available

Actual

-$0.38 -

Consensus

-

Report Date

Year Ago

-0.51

Year Ago Change %

Up 25%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites